Skip to main navigation
Skip to content
Aerpio Pharmaceuticals
  • Home
  • About Us
    • The Company
    • Leadership
    • Clinical Advisors
    • Board
    • Careers
  • Our Science
    • The mTOR Pathway
    • The Product
    • Publications and Abstracts
  • Pipeline
    • Pipeline Clinical Studies
    • Advanced PEComa
    • TSC1 and TSC2 Inactivating Alterations
  • Expanded Access
  • Contact
Aerpio Pharmaceuticals

Breadcrumb

  • Home >>
  • Investors >>
  • sec filings >>
  • 0001209191 22 023351 >>

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
04/05/22
Document Date
04/01/22
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Aadi Bioscience, Inc.
Issuer
AADI BIOSCIENCE, INC.
Filer
ITRI LORETTTA M

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • IR Contacts

Investor Relations

  • Investor Overview
  • Stock Information
    • Stock Quote & Chart
  • Press Releases
  • Event Calendar
  • Corporate Presentations
  • Scientific Presentations
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
    • Forms
  • Corporate Governance
    • Governance Highlights
    • Committee Composition
  • Investor Resources
    • Investor FAQ
    • Information Request
    • E-mail Alerts
    • IR Contacts
  • Home
  • Leadership
  • Pipeline
  • Contact
  • Careers